Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-31

FDA Approved: QUINAPRIL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for a quinapril hydrochloride generic product manufactured by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quinapril (quinapril)

Snippet

SUPPL AP for QUINAPRIL (QUINAPRIL HYDROCHLORIDE)